icon-folder.gif   Conference Reports for NATAP  
 
 

16thEuro

Back grey_arrow_rt.gif
 
 
 
ABX464 Decreases Total HIV DNA and Integrated HIV DNA in PBMCs When Administered During 28 Days to HIV-infected Virologically Suppressed Patients
 
 
  Reported by Jules Levin
16th European Aids Conference
Milano
October 26, 2017
 
Linos Vandekerckhove 1 , Roger Paredes 2, Bonaventura Clotet 2, Michel Moutschen 3, Stéphane De Wit 4, Daniel Podzamczer 5, Laurent Cotte 6, Jacques Reynes 7, Sofie Rutsaert 1, Basiel Cole 1 , Sam Kint 1 , Paul Gineste 8, Hartmut Ehrlich 8, Jean-Marc Steens 8*
 
1HIV Cure Research Center, Internal Medicine and Infectious Diseases, Ghent University Hospital, Ghent, Belgium; 2Infectious Diseases & IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; 3Médecine Interne/infectiologie CHU Sart Tilman, Liege, Belgium; 4C.H.U. Saint-Pierre, Brussels, Belgium; 5Hospital Universitari de Bellvitge, Barcelona, Spain; 6Hopital de la Croix-Rousse, Lyon, France; 7Hopital Gui de Chauliac, Montpellier, France; 8ABIVAX, Paris, France. *Corresponding author: jean-marc.steens@abivax.com

1030171

1030172

1030173

1030174

1030175

1030176

1030177